<DOC>
	<DOCNO>NCT00535080</DOCNO>
	<brief_summary>The aim study provide investigational drug patient optimally treat conventional therapy collect efficacy safety data use Metvix PDT subject field actinic keratoses , large/multiple superficial basal cell carcinoma ( BCCs ) Bowen 's disease .</brief_summary>
	<brief_title>Compassionate Use MetvixÂ® ( Methyl Aminolevulinate ) Photodynamic Therapy ( PDT ) Subjects With Field Actinic Keratoses , Large/Multiple Superficial Basal Cell Carcinomas ( BCCs ) , Bowen 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<mesh_term>Carcinoma , Basal Cell</mesh_term>
	<mesh_term>Bowen 's Disease</mesh_term>
	<mesh_term>Aminolevulinic Acid</mesh_term>
	<mesh_term>Methyl 5-aminolevulinate</mesh_term>
	<criteria>Male female subject old 18 year . Subject presenting : Either field actinic keratoses ( AKs ) ( mild moderate , multiple cluster AKs severely sundamaged skin ) ; Biopsyconfirmed large , multiple ( several anatomical area ) primary superficial BCC lesion macroscopically histologically consistent superficial basal cell carcinoma ( sBCC ) histological evidence aggressive growth pattern ; Histologically confirm diagnosis Bowen 's disease biopsy take within 3 month Any subject presenting aforementioned lesion must able treat optimally conventional therapy . Female subject childbearing potential , use effective birth control method ( see Case Report Form ) negative pregnancy test beginning study , female subject non childbearing potential Subject must willing capable cooperate extent degree require protocol . Subject read Patient Information Sheet read sign Informed Consent form prior study related procedure . A recurrent superficial BCC lesion previously treat . Subject whose lesion select treatment zone ( include 5 cm margin around treatment area ) treat follow topical treatment within specify washout period : 5FU 3 month Cryotherapy 3 month Imiquimod 3 month PDT 3 month Diclofenac sodium 3 month Surgery , radiotherapy , curettage , electrodesiccation , retinoids , dermabrasion , laser resurfacing , salicylic acid 3 month A primary superficial BCC locate close involve scar SCC Subject know porphyria . Subject target lesion genitals . Subject know xeroderma pigmentosum . Pigmented lesion ( ) treat area . Morpheaform lesion ( ) treat area . Infiltrating lesion ( ) treat area . Female subject pregnant , nurse plan pregnancy study . Subject known hypersensitivity methyl 5aminolevulinate , similar compound excipients cream . Subject participate another investigational drug device research study within 30 day enrolment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>actinic</keyword>
	<keyword>keratoses</keyword>
	<keyword>superficial</keyword>
	<keyword>basal</keyword>
	<keyword>carcinoma</keyword>
	<keyword>Bowen 's</keyword>
	<keyword>large multiple superficial Basal Carcinomas</keyword>
</DOC>